Tobinco values vindication over GHC94M judgment debt amid inflation impact

Elder Dr. Samuel Amo Tobbin, Chairman of Tobinco Pharmaceuticals, has stated that he prioritizes vindication over a GHC94 million judgment debt awarded by the court after a decade-long legal battle with the FDA.

Dr. Tobbin emphasizes that clearing his name from false accusations of importing fake drugs is more important than financial compensation.

Despite being awarded GHC93.9 million, Tobbin reflects on how inflation over eight years has significantly increased the amount from the original GHC24 million calculated by the court.